Document Detail

A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma.
MedLine Citation:
PMID:  20826029     Owner:  NLM     Status:  In-Process    
PURPOSE: A multi-center prospective randomized trial was conducted to evaluate the efficacy and safety of Actovegin in the prevention and treatment of chemoradiotherapy-induced acute oral mucositis.
METHODS AND MATERIALS: Between February 2006 and May 2007, 156 evaluable patients with nasopharyngeal carcinoma were randomized to Group 1 (n=53) for prevention, Group 2 (n=51) for treatment, and Group 3 (n=52) for control. All patients received concomitant chemoradiotherapy ± induction chemotherapy. Radiation technique and dose were similar among 3 groups. Intravenous Actovegin of 30 ml daily (5 days/week) was administrated from day 1 of the radiotherapy for Group 1 and from the onset of grade 2 mucositis for Group 2, until the end of the radiotherapy.
RESULTS: The incidence of grade 3 mucositis was lower in Group 1 compared with Group 3 (26.4% vs. 55.8%, P=0.002). Group 2 had a lower progression rate of mucositis from grade 2 to 3 compared with Group 3 (39.2% vs. 60.4%, P=0.035). There was no difference in the onset time of grade 3 mucositis among 3 groups. Actovegin was well tolerated and no treatment-related adverse events were observed.
CONCLUSIONS: Actovegin is effective in the prevention and treatment of chemoradiotherapy-induced oral mucositis.
Shao-Xiong Wu; Tian-Tian Cui; Chong Zhao; Jian-Ji Pan; Bing-Yu Xu; Ye Tian; Nian-Ji Cui
Related Documents :
11256729 - History and evidence-based medicine: lessons from the history of somatic treatments fro...
17570009 - Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and c...
16549699 - Nasogastric intubation after abdominal surgery: a meta-analysis of recent literature.
18953819 - Is laparoscopic resection appropriate for colorectal adenocarcinoma?
11085349 - Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a...
10495109 - Standard effective doses for proliferative tumours.
20535699 - Ventral bulbar augmentation: a new technical modification of oral mucosa graft urethrop...
10750769 - Craniocervical and aortic atherosclerosis as neurologic risk factors in coronary surgery.
2714149 - Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis.
Publication Detail:
Type:  Journal Article     Date:  2010-09-07
Journal Detail:
Title:  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology     Volume:  97     ISSN:  1879-0887     ISO Abbreviation:  Radiother Oncol     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8407192     Medline TA:  Radiother Oncol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  113-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer r...
Next Document:  Increased use of regional radiotherapy is associated with improved outcome in a population-based coh...